Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

PHASE3CompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

December 11, 2014

Primary Completion Date

May 31, 2019

Study Completion Date

July 3, 2020

Conditions
Chronic Kidney Disease
Interventions
DRUG

Everolimus

Active Comparator

DRUG

Tacrolimus

Active Comparator

DRUG

Mycophenolate sodium

Experimental Arm

Trial Locations (14)

14033

Caen University Hospital, Caen

29200

Brest University Hospital, Brest

35000

Rennes University Hospital, Rennes

37000

Tours University Hospital, Tours

49100

Angers University Hospital, Angers

51000

Reims University Hospital, Reims

63000

Clermont Ferrand University Hospital, Clermont-Ferrand

67000

Strasbourg University Hospital, Strasbourg

75015

Georges Pompidou European Hospital, Paris

Necker Hospital, Paris

76000

Rouen University Hospital, Rouen

80000

Amiens University Hospital, Amiens

86000

Poitiers University Hospital, Poitiers

87000

Limoges University Hospital, Limoges

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT02334488 - Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function | Biotech Hunter | Biotech Hunter